Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker RCUS
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Alexander Azoy Officer | RCUS Arcus Biosciences, Inc. | 2,827 | $83.5K | 10b5-1 | Aug 21, 2026 | Form 4 ↗ 3 days later · 2,827 shares | Form 144 ↗ |
| Jul 9, 2026 | Juan Jaen Officer | RCUS Arcus Biosciences, Inc. | 25,000 | $749.0K | 10b5-1 | Jul 9, 2026 | Form 4 ↗ 4 days later · 68,569 shares | Form 144 ↗ |
| Jun 24, 2026 | Juan Jaen Officer | RCUS Arcus Biosciences, Inc. | 50,000 | $1.4M | 10b5-1 | Jun 24, 2026 | Form 4 ↗ same day · 31,431 shares | Form 144 ↗ |
| Jun 22, 2026 | Juan Jaen Officer | RCUS Arcus Biosciences, Inc. | 25,000 | $680.8K | 10b5-1 | Jun 22, 2026 | Form 4 ↗ 2 days later · 31,431 shares | Form 144 ↗ |
| Jun 1, 2026 | Alexander Azoy Officer | RCUS Arcus Biosciences, Inc. | 2,562 | $64.9K | 10b5-1 | Jun 1, 2026 | Form 4 ↗ same day · 2,562 shares | Form 144 ↗ |
| May 11, 2026 | Robert C. Goeltz II Officer | RCUS Arcus Biosciences, Inc. | 7,763 | $199.0K | 10b5-1 | May 11, 2026 | Form 4 ↗ 1 day later · 7,763 shares | Form 144 ↗ |
| May 6, 2026 | Jennifer Jarrett Officer | RCUS Arcus Biosciences, Inc. | 77,793 | $1.9M | — | May 6, 2026 | — | Form 144 ↗ |
| Apr 23, 2026 | Jennifer Jarrett Officer | RCUS Arcus Biosciences, Inc. | 53,826 | $1.4M | — | Apr 23, 2026 | — | Form 144 ↗ |
| Apr 8, 2026 | Jennifer Jarrett Officer | RCUS Arcus Biosciences, Inc. | 70,000 | $1.6M | — | Apr 8, 2026 | — | Form 144 ↗ |
| Jan 5, 2026 | Juan Jaen Officer | RCUS Arcus Biosciences, Inc. | 31,823 | $692.8K | 10b5-1 | Jan 5, 2026 | Form 4 ↗ 2 days later · 31,823 shares | Form 144 ↗ |
| Dec 31, 2025 | Robert C. Goeltz II Officer | RCUS Arcus Biosciences, Inc. | 6,552 | $153.2K | 10b5-1 | Dec 31, 2025 | Form 4 ↗ 2 days later · 6,552 shares | Form 144 ↗ |
| Dec 18, 2025 | Alexander Azoy Officer | RCUS Arcus Biosciences, Inc. | 4,343 | $96.8K | 10b5-1 | Dec 18, 2025 | Form 4 ↗ same day · 8,832 shares | Form 144 ↗ |
| Dec 15, 2025 | Richard Markus Officer | RCUS Arcus Biosciences, Inc. | 10,000 | $219.0K | 10b5-1 | Dec 16, 2025 | Form 4 ↗ 3 days later · 9,546 shares | Form 144 ↗ |
| Dec 15, 2025 | Carolyn Tang Officer | RCUS Arcus Biosciences, Inc. | 15,000 | $328.5K | 10b5-1 | Dec 16, 2025 | Form 4 ↗ 3 days later · 14,468 shares | Form 144 ↗ |
| Dec 15, 2025 | Alexander Azoy Officer | RCUS Arcus Biosciences, Inc. | 5,000 | $109.5K | 10b5-1 | Dec 16, 2025 | Form 4 ↗ 3 days later · 8,832 shares | Form 144 ↗ |
| Dec 15, 2025 | Jennifer Jarrett Officer | RCUS Arcus Biosciences, Inc. | 22,000 | $481.8K | 10b5-1 | Dec 16, 2025 | Form 4 ↗ 3 days later · 21,208 shares | Form 144 ↗ |
| Dec 15, 2025 | Robert C. Goeltz, II Officer | RCUS Arcus Biosciences, Inc. | 14,000 | $306.6K | 10b5-1 | Dec 16, 2025 | Form 4 ↗ 3 days later · 12,662 shares | Form 144 ↗ |
| Dec 15, 2025 | Juan Jaen Officer | RCUS Arcus Biosciences, Inc. | 22,000 | $481.8K | 10b5-1 | Dec 16, 2025 | Form 4 ↗ 3 days later · 21,208 shares | Form 144 ↗ |
| Dec 15, 2025 | Terry Rosen, Ph.D. Officer, Director | RCUS Arcus Biosciences, Inc. | 55,000 | $1.2M | 10b5-1 | Dec 16, 2025 | Form 4 ↗ 3 days later · 54,691 shares | Form 144 ↗ |
| Dec 4, 2025 | Juan Jaen Officer | RCUS Arcus Biosciences, Inc. | 82,997 | $2.1M | 10b5-1 | Dec 4, 2025 | Form 4 ↗ 1 day later · 82,997 shares | Form 144 ↗ |
| Nov 26, 2025 | Alexander Azoy Officer | RCUS Arcus Biosciences, Inc. | 1,900 | $46.1K | 10b5-1 | Nov 26, 2025 | Form 4 ↗ 5 days later · 1,900 shares | Form 144 ↗ |
| Nov 26, 2025 | Robert C. Goeltz II Officer | RCUS Arcus Biosciences, Inc. | 5,000 | $125.0K | 10b5-1 | Nov 26, 2025 | Form 4 ↗ same day · 5,000 shares | Form 144 ↗ |
| Nov 17, 2025 | Juan Jaen Officer | RCUS Arcus Biosciences, Inc. | 50,000 | $999.5K | 10b5-1 | Nov 17, 2025 | Form 4 ↗ 2 days later · 50,000 shares | Form 144 ↗ |
| Oct 30, 2025 | Juan Jaen Officer | RCUS Arcus Biosciences, Inc. | 1,173 | $23.7K | 10b5-1 | Oct 30, 2025 | Form 4 ↗ 4 days later · 4,314 shares | Form 144 ↗ |
| Oct 28, 2025 | Juan Jaen Officer | RCUS Arcus Biosciences, Inc. | 100,000 | $2.0M | 10b5-1 | Oct 28, 2025 | Form 4 ↗ 2 days later · 96,859 shares | Form 144 ↗ |
| Oct 28, 2025 amended | Robert C. Goeltz II Officer | RCUS Arcus Biosciences, Inc. | 5,000 | $100.0K | 10b5-1 | Oct 28, 2025 | Form 4 ↗ 1 day later · 5,000 shares | Form 144/A ↗ |
| Oct 28, 2025 | Robert C. Goeltz II Officer | RCUS Arcus Biosciences, Inc. | 5,000 | $100.0K | — | Oct 28, 2025 | Form 4 ↗ 1 day later · 5,000 shares | Form 144 ↗ |
| Oct 6, 2025 | Jennifer Jarrett Officer | RCUS Arcus Biosciences, Inc. | 100,583 | $1.3M | 10b5-1 | Oct 6, 2025 | Form 4 ↗ 2 days later · 50,292 shares | Form 144 ↗ |
| Sep 29, 2025 | Alexander Azoy Officer | RCUS Arcus Biosciences, Inc. | 2,831 | $36.4K | 10b5-1 | Sep 29, 2025 | Form 4 ↗ 1 day later · 2,831 shares | Form 144 ↗ |
| Sep 5, 2025 | Alexander Azoy Officer | RCUS Arcus Biosciences, Inc. | 1,579 | $18.3K | 10b5-1 | Sep 5, 2025 | Form 4 ↗ same day · 1,579 shares | Form 144 ↗ |
| Dec 31, 2024 | Goeltz II Robert C. Officer | RCUS Arcus Biosciences, Inc. | 3,594 | $53.9K | 10b5-1 | Dec 31, 2024 | Form 4 ↗ 3 days later · 3,594 shares | Form 144 ↗ |
| Mar 27, 2024 | Jennifer Jarrett Officer | RCUS Arcus Biosciences, Inc. | 56,551 | $955.7K | 10b5-1 | Mar 27, 2024 | — | Form 144 ↗ |
| Mar 15, 2024 | Jennifer Jarrett Officer | RCUS Arcus Biosciences, Inc. | 16,000 | $296.0K | 10b5-1 | Mar 18, 2024 | — | Form 144 ↗ |
| Jan 4, 2024 amended | Juan Jaen Officer | RCUS Arcus Biosciences, Inc. | 100,000 | $2.0M | 10b5-1 | Jan 2, 2024 | — | Form 144/A ↗ |
| Jan 2, 2024 | Goeltz II Robert C. Officer | RCUS Arcus Biosciences, Inc. | 2,004 | $40.1K | 10b5-1 | Jan 2, 2024 | — | Form 144 ↗ |
| Jan 2, 2024 | Juan Jaen Officer | RCUS Arcus Biosciences, Inc. | 100,000 | $2.0M | 10b5-1 | Jan 2, 2024 | — | Form 144 ↗ |
| Dec 22, 2023 | Jennifer Jarrett Officer, Director | RCUS Arcus Biosciences, Inc. | 80,146 | $1.4M | 10b5-1 | Dec 22, 2023 | — | Form 144 ↗ |
| Dec 15, 2023 | Carolyn Tang Officer | RCUS Arcus Biosciences, Inc. | 5,600 | $98.0K | 10b5-1 | Dec 18, 2023 | — | Form 144 ↗ |
| Dec 15, 2023 | Dimitry Nuyten Officer | RCUS Arcus Biosciences, Inc. | 3,500 | $61.3K | 10b5-1 | Dec 18, 2023 | — | Form 144 ↗ |
| Dec 15, 2023 | Robert C. Goeltz, II Officer | RCUS Arcus Biosciences, Inc. | 5,500 | $96.3K | 10b5-1 | Dec 18, 2023 | — | Form 144 ↗ |
| Dec 15, 2023 | Jennifer Jarrett Officer, Director | RCUS Arcus Biosciences, Inc. | 16,000 | $280.0K | 10b5-1 | Dec 18, 2023 | — | Form 144 ↗ |
| Dec 15, 2023 | Juan Jaen Officer, Director | RCUS Arcus Biosciences, Inc. | 8,500 | $148.8K | 10b5-1 | Dec 18, 2023 | — | Form 144 ↗ |
| Dec 15, 2023 | Terry Rosen Officer, Director | RCUS Arcus Biosciences, Inc. | 19,000 | $332.5K | 10b5-1 | Dec 18, 2023 | — | Form 144 ↗ |
| Sep 22, 2023 | Jennifer Jarrett Officer, Director | RCUS Arcus Biosciences, Inc. | 57,494 | $1.2M | 10b5-1 | Sep 22, 2023 | — | Form 144 ↗ |
| Sep 15, 2023 | Dimitry Nuyten Officer | RCUS Arcus Biosciences, Inc. | 6,000 | $124.4K | 10b5-1 | Sep 18, 2023 | — | Form 144 ↗ |
| Sep 15, 2023 | Jennifer Jarrett Officer, Director | RCUS Arcus Biosciences, Inc. | 13,000 | $269.6K | 10b5-1 | Sep 18, 2023 | — | Form 144 ↗ |
| Jun 22, 2023 | Jennifer Jarrett Officer, Director | RCUS Arcus Biosciences, Inc. | 57,437 | $1.1M | 10b5-1 | Jun 22, 2023 | — | Form 144 ↗ |
| Jun 15, 2023 | Carolyn Tang Officer | RCUS Arcus Biosciences, Inc. | 3,500 | $70.0K | 10b5-1 | Jun 16, 2023 | — | Form 144 ↗ |
| Jun 15, 2023 | Jennifer Jarrett Officer, Director | RCUS Arcus Biosciences, Inc. | 13,500 | $270.0K | 10b5-1 | Jun 16, 2023 | — | Form 144 ↗ |
| Jun 15, 2023 | Juan Jaen Officer, Director | RCUS Arcus Biosciences, Inc. | 5,500 | $110.0K | 10b5-1 | Jun 16, 2023 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:55 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances